Grace Therapeutics, Inc. · Brief

Next report

9 days

Nov 12 · before openest.Q2 FY27

Expected move

±41.1%implied · straddle

1.072.55

spot 1.81exp Nov 20ATM strike 2.5ATM straddle 0.87IV 188%

Nov 2 close

Expected move

—≥ implied

Q1 FY27±19.3%▼−1.43%×0.07

quarterimplied−20%0+20%realized×

Q1 FY27±19.3%▼−1.43%×0.07

Shaded = implied · tick ▲▼ = realized · × = |realized| ÷ impliedSource: options EOD · implied at prior close · realized close to close

Nov 12 report · est.

Bull2

33managers reporting a position in the latest quarterly filings13F · Jun 30 '26

+12.06%change in shares held by the ten largest reporting managers over the latest quarter13F · Jun 30 '26

Bear2

8managers whose positions together make up four fifths of the reported value13F · Jun 30 '26

4 of 15of the largest reporting managers cut their stake in the latest quarter13F · Jun 30 '26

AI captions · Sep 28 '26once per report · top 2 per case

GRCE report session

No linked exposure.

Oct 29impliedImplied move: ±35.1% into Nov 12 earnings (Oct 29 close).Source

privateThesis 0 · Decisions 0 · Observations 0

No thesis.